<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01895153</url>
  </required_header>
  <id_info>
    <org_study_id>2012-03-029</org_study_id>
    <nct_id>NCT01895153</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome</brief_title>
  <official_title>The Efficacy of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy in Patients With Bladder Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The efficacy of pentosan polysulfate sodium, hydrodistension and combination therapy in
      patients with bladder pain syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the change of IC-Q symptom index(ICSI)score from baseline to 6 months after each treatment</measure>
    <time_frame>6months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of voiding dairy parameters(mean number of micturition,Urgency etc) after each treatment.</measure>
    <time_frame>1,2,4 and 6months after each treatment .</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of O'Leary-Sant Intersttial Cystitis questionnaire (IC-Q)score after each treatment</measure>
    <time_frame>1,2,4 and 6months after each treatment .</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF)</measure>
    <time_frame>1,2,4 and 6months after each treatment .</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Global Response Assessment(GRA) score</measure>
    <time_frame>1,2,4 and 6months after each treatment .</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of EQ-5D Health Questionnaire score</measure>
    <time_frame>1,2,4 and 6months after each treatment .</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Brief Pain Inventory-short form(BPI-sf) score</measure>
    <time_frame>1 and 6months after each treatment.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The estimation of safty and Complications for each treatment</measure>
    <time_frame>1,2,4 and 6months after each treatment .</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Bladder Pain Syndrome</condition>
  <condition>Pentosan Polysulfate</condition>
  <condition>Hydrodistension</condition>
  <arm_group>
    <arm_group_label>pentosan polysulfate cohort</arm_group_label>
    <description>pentosan polysulfate monotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hydrodistension(HD) cohort</arm_group_label>
    <description>hydrodistension(HD) monotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>combination cohort</arm_group_label>
    <description>combination therapy of pentosan polysulfate and hydrodistension.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Bladder pain syndrome patients have not been treated with hydrodistention.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. men and women who were over 18 years old and had symptoms over 6 months.

          2. 4 or more with an pain visual analogue score

          3. 12 or more O'Leary-Sant Intersttial Cystitis questionnaire (IC-Q) symptom and problem
             score and with a pain score and nocturia score of 2 or more.

        Exclusion Criteria:

          1. history of hydrodistention,augumentation cystoplasty due to IC/BPS

          2. pentosan polysulfate sodium (Elmiron) history over 1 month within 6 months.

          3. Women of child-bearing potential who were pregnant or nursing

          4. mean voided volume lesser than 40ml or over than 400ml.

          5. hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.

          6. urinary tract infection during run-in periods.

          7. genitourinary tuberculosis or bladder,urethral and prostate cancer

          8. recurrent urinary tract infection

          9. history of hystrectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal
             delivery or Cesarean section,prostate opreation or treatment etc within 6months.

         10. neurologic disease history of cerebral infaction,multiple sclerosis or parkinsonism
             etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyu-Sung Lee, MD,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyu-Sung Lee, M.D., Ph.D.</last_name>
    <phone>82-2-3410-3554</phone>
    <email>keleedr@skku.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hyun Wook You, M.D.</last_name>
    <phone>82-2-3410-1268</phone>
    <email>khdoct29@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyu-Sung Lee, M.D., Ph.D.</last_name>
      <phone>82-2-3410-3554</phone>
      <email>ksleedr@skku.edu</email>
    </contact>
    <contact_backup>
      <last_name>Hyun Wook You, MD.</last_name>
      <phone>80-2-3410-1268</phone>
      <email>khdoct29@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2013</study_first_submitted>
  <study_first_submitted_qc>July 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2013</study_first_posted>
  <last_update_submitted>February 12, 2015</last_update_submitted>
  <last_update_submitted_qc>February 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>KYU-SUNG LEE</investigator_full_name>
    <investigator_title>professor,MD,PhD</investigator_title>
  </responsible_party>
  <keyword>bladder pain syndrome</keyword>
  <keyword>pentosan polysulfate</keyword>
  <keyword>hydrodistension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
    <mesh_term>Cystitis, Interstitial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pentosan Sulfuric Polyester</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

